CA2098298A1 - Formulations en aerosol - Google Patents

Formulations en aerosol

Info

Publication number
CA2098298A1
CA2098298A1 CA002098298A CA2098298A CA2098298A1 CA 2098298 A1 CA2098298 A1 CA 2098298A1 CA 002098298 A CA002098298 A CA 002098298A CA 2098298 A CA2098298 A CA 2098298A CA 2098298 A1 CA2098298 A1 CA 2098298A1
Authority
CA
Canada
Prior art keywords
aerosol
salt
monohydrate
ethanediamine
carboxyethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002098298A
Other languages
English (en)
Inventor
Susan M. Milosovich
Cynthia S. Randall
William F. Rencher
Thomas M. Rossi
Kerry J. Gombatz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2098298A1 publication Critical patent/CA2098298A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/56Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002098298A 1990-12-19 1991-03-28 Formulations en aerosol Abandoned CA2098298A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US63011490A 1990-12-19 1990-12-19
US07/630,114 1990-12-19
US64585091A 1991-01-25 1991-01-25
US07/645,850 1991-01-25

Publications (1)

Publication Number Publication Date
CA2098298A1 true CA2098298A1 (fr) 1992-06-20

Family

ID=27091083

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002098298A Abandoned CA2098298A1 (fr) 1990-12-19 1991-03-28 Formulations en aerosol

Country Status (8)

Country Link
EP (1) EP0563048A1 (fr)
JP (1) JPH06503066A (fr)
KR (1) KR930703251A (fr)
AU (1) AU8642391A (fr)
CA (1) CA2098298A1 (fr)
IE (1) IE913482A1 (fr)
PT (1) PT99869A (fr)
WO (1) WO1992011236A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
ME00220B (me) 2000-05-22 2010-10-10 Chiesi Farm Spa Stabilne farmaceutske formulacije rastvora za inhalatore odmjerene doze pod pritiskom
ES2222294T3 (es) 2001-07-02 2005-02-01 Chiesi Farmaceutici S.P.A. Formulacion optimizada de tobramicina para administracion en forma de aerosol.
EP1595531A1 (fr) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Formulation d'une solution pharmaceutique stable pour aérosols doseurs sous pression

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874792A (en) * 1985-04-19 1989-10-17 Smithkline Beckman Corporation Thiophenyl Alkanoic acids useful as leukotriene antagonists

Also Published As

Publication number Publication date
PT99869A (pt) 1992-11-30
JPH06503066A (ja) 1994-04-07
EP0563048A1 (fr) 1993-10-06
KR930703251A (ko) 1993-11-29
IE913482A1 (en) 1992-07-01
AU8642391A (en) 1992-07-22
WO1992011236A1 (fr) 1992-07-09

Similar Documents

Publication Publication Date Title
US4005222A (en) Mucolytic mercaptoacylamidobenzoic and benzenesulfonic acid compounds and process
US8765153B2 (en) Levalbuterol salt
CA2098298A1 (fr) Formulations en aerosol
EP0365119B1 (fr) Composition pharmaceutique
US4132803A (en) Mercaptoacylamidobenzoylglycine mucolytic process and compositions
KR101066801B1 (ko) 항콜린제를 함유하는 hfa- 현탁 제형
CA2183557A1 (fr) Formule d'un aerosol medicamenteux contenant de la vitamine e
JPH03184967A (ja) フロセミド塩、それらの製造法、薬剤としての使用及びそれらを含有する製薬組成物
NZ232594A (en) Aerosol formulation of nedocromil sodium

Legal Events

Date Code Title Description
FZDE Dead